Samsara Bio Capital, LLC Sutro Biopharma, Inc. Transaction History
Samsara Bio Capital, LLC
- $233 Million
- Q2 2025
A detailed history of Samsara Bio Capital, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 2,196,814 shares of STRO stock, worth $1.71 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
2,196,814
Previous 2,196,814
-0.0%
Holding current value
$1.71 Million
Previous $1.43 Million
9.25%
% of portfolio
0.67%
Previous 0.66%
Shares
5 transactions
Others Institutions Holding STRO
# of Institutions
107Shares Held
59.3MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$5.39 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$5.06 Million0.16% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$3.97 Million0.43% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$3.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$3.21 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $40.7M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...